Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

An attenuated strain of Bacillus anthracis (CDC 684) has a large chromosomal inversion and altered growth kinetics.

Okinaka RT, Price EP, Wolken SR, Gruendike JM, Chung WK, Pearson T, Xie G, Munk C, Hill KK, Challacombe J, Ivins BE, Schupp JM, Beckstrom-Sternberg SM, Friedlander A, Keim P.

BMC Genomics. 2011 Sep 30;12:477. doi: 10.1186/1471-2164-12-477.

2.

A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibiotics.

Vietri NJ, Purcell BK, Tobery SA, Rasmussen SL, Leffel EK, Twenhafel NA, Ivins BE, Kellogg MD, Webster WM, Wright ME, Friedlander AM.

J Infect Dis. 2009 Feb 1;199(3):336-41. doi: 10.1086/596063.

PMID:
19099484
3.

Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.

Heine HS, Bassett J, Miller L, Bassett A, Ivins BE, Lehoux D, Arhin FF, Parr TR Jr, Moeck G.

Antimicrob Agents Chemother. 2008 Sep;52(9):3350-7. doi: 10.1128/AAC.00360-08. Epub 2008 Jul 7.

4.

An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals.

Hewetson JF, Little SF, Ivins BE, Johnson WM, Pittman PR, Brown JE, Norris SL, Nielsen CJ.

Vaccine. 2008 Aug 5;26(33):4262-6. doi: 10.1016/j.vaccine.2008.05.068. Epub 2008 Jun 12.

PMID:
18586363
5.

Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.

Heine HS, Bassett J, Miller L, Hartings JM, Ivins BE, Pitt ML, Fritz D, Norris SL, Byrne WR.

Antimicrob Agents Chemother. 2007 Apr;51(4):1373-9. Epub 2007 Feb 12.

6.

Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine.

Little SF, Ivins BE, Webster WM, Norris SL, Andrews GP.

Vaccine. 2007 Apr 12;25(15):2771-7. Epub 2007 Jan 2.

PMID:
17240008
7.

CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine.

Klinman DM, Xie H, Ivins BE.

Ann N Y Acad Sci. 2006 Oct;1082:137-50. Review.

PMID:
17145935
8.

Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.

Vietri NJ, Purcell BK, Lawler JV, Leffel EK, Rico P, Gamble CS, Twenhafel NA, Ivins BE, Heine HS, Sheeler R, Wright ME, Friedlander AM.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7813-6. Epub 2006 May 3.

9.

Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.

Ribot WJ, Powell BS, Ivins BE, Little SF, Johnson WM, Hoover TA, Norris SL, Adamovicz JJ, Friedlander AM, Andrews GP.

Vaccine. 2006 Apr 24;24(17):3469-76. Epub 2006 Feb 21.

PMID:
16519970
10.

Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.

Little SF, Ivins BE, Webster WM, Fellows PF, Pitt ML, Norris SL, Andrews GP.

Vaccine. 2006 Mar 24;24(14):2530-6. Epub 2005 Dec 27.

PMID:
16417950
11.
12.

CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques.

Klinman DM, Xie H, Little SF, Currie D, Ivins BE.

Vaccine. 2004 Jul 29;22(21-22):2881-6.

PMID:
15246624
13.

Development of an in vitro-based potency assay for anthrax vaccine.

Little SF, Webster WM, Ivins BE, Fellows PF, Norris SL, Andrews GP.

Vaccine. 2004 Jul 29;22(21-22):2843-52.

PMID:
15246620
14.

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.

Little SF, Ivins BE, Fellows PF, Pitt ML, Norris SL, Andrews GP.

Vaccine. 2004 Jan 2;22(3-4):422-30.

PMID:
14670324
15.

Anthrax vaccines.

Friedlander AM, Welkos SL, Ivins BE.

Curr Top Microbiol Immunol. 2002;271:33-60. Review.

PMID:
12224523
16.

Anthrax vaccine efficacy in golden Syrian hamsters.

Fellows PF, Linscott MK, Little SF, Gibbs P, Ivins BE.

Vaccine. 2002 Jan 31;20(9-10):1421-4.

PMID:
11818161
17.

In vitro correlate of immunity in a rabbit model of inhalational anthrax.

Pitt ML, Little SF, Ivins BE, Fellows P, Barth J, Hewetson J, Gibbs P, Dertzbaugh M, Friedlander AM.

Vaccine. 2001 Sep 14;19(32):4768-73.

PMID:
11535328
18.

Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin.

Fellows PF, Linscott MK, Ivins BE, Pitt ML, Rossi CA, Gibbs PH, Friedlander AM.

Vaccine. 2001 Apr 30;19(23-24):3241-7. Erratum in: Vaccine 2001 Nov 12;20(3-4):635.

PMID:
11312020
19.

Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure.

Hail AS, Rossi CA, Ludwig GV, Ivins BE, Tammariello RF, Henchal EA.

Mil Med. 1999 Dec;164(12):833-7.

PMID:
10628152
20.

Molecular pathogenesis of Bacillus anthracis infection.

Little SF, Ivins BE.

Microbes Infect. 1999 Feb;1(2):131-9. Review.

PMID:
10594977
21.

In vitro correlate of immunity in an animal model of inhalational anthrax

Pitt ML, Little S, Ivins BE, Fellows P, Boles J, Barth J, Hewetson J, Friedlander AM.

J Appl Microbiol. 1999 Aug;87(2):304.

22.

The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation.

Zaucha GM, Pitt LM, Estep J, Ivins BE, Friedlander AM.

Arch Pathol Lab Med. 1998 Nov;122(11):982-92.

PMID:
9822127
23.

Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques.

Ivins BE, Pitt ML, Fellows PF, Farchaus JW, Benner GE, Waag DM, Little SF, Anderson GW Jr, Gibbs PH, Friedlander AM.

Vaccine. 1998 Jul;16(11-12):1141-8.

PMID:
9682372
24.
25.

Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs.

Little SF, Ivins BE, Fellows PF, Friedlander AM.

Infect Immun. 1997 Dec;65(12):5171-5.

26.
27.

Postexposure prophylaxis against experimental inhalation anthrax.

Friedlander AM, Welkos SL, Pitt ML, Ezzell JW, Worsham PL, Rose KJ, Ivins BE, Lowe JR, Howe GB, Mikesell P, et al.

J Infect Dis. 1993 May;167(5):1239-43.

PMID:
8486963
28.

Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants.

Ivins BE, Welkos SL, Little SF, Crumrine MH, Nelson GO.

Infect Immun. 1992 Feb;60(2):662-8.

29.

Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.

Iacono-Connors LC, Welkos SL, Ivins BE, Dalrymple JM.

Infect Immun. 1991 Jun;59(6):1961-5.

31.

Influence of body weight on response of Fischer 344 rats to anthrax lethal toxin.

Ivins BE, Ristroph JD, Nelson GO.

Appl Environ Microbiol. 1989 Aug;55(8):2098-100.

32.

Recent advances in the development of an improved, human anthrax vaccine.

Ivins BE, Welkos SL.

Eur J Epidemiol. 1988 Mar;4(1):12-9. Review.

PMID:
3128450
33.

Transposon Tn916 mutagenesis in Bacillus anthracis.

Ivins BE, Welkos SL, Knudson GB, Leblanc DJ.

Infect Immun. 1988 Jan;56(1):176-81.

34.
35.

Immunization studies with attenuated strains of Bacillus anthracis.

Ivins BE, Ezzell JW Jr, Jemski J, Hedlund KW, Ristroph JD, Leppla SH.

Infect Immun. 1986 May;52(2):454-8.

36.

Demonstration of a capsule plasmid in Bacillus anthracis.

Green BD, Battisti L, Koehler TM, Thorne CB, Ivins BE.

Infect Immun. 1985 Aug;49(2):291-7.

38.

Synthesis and secretion of the plasmid-coded heat-labile enterotoxin of Escherichia coli in Vibrio cholerae.

Neill RJ, Ivins BE, Holmes RK.

Science. 1983 Jul 15;221(4607):289-91.

PMID:
6857285
39.

Elaboration of Bacillus anthracis antigens in a new, defined culture medium.

Ristroph JD, Ivins BE.

Infect Immun. 1983 Jan;39(1):483-6.

40.

Evidence for plasmid-mediated toxin production in Bacillus anthracis.

Mikesell P, Ivins BE, Ristroph JD, Dreier TM.

Infect Immun. 1983 Jan;39(1):371-6.

41.
42.
44.

A simple method for the multiple tissue culture assay of Chlamydia trachomatis.

Ivins BE, Wyrick PB.

Med Lab Sci. 1978 Oct;35(4):407-8. No abstract available.

PMID:
368489
45.

Interaction of Chlamydia psittaci with mouse peritoneal macrophages.

Wyrick PB, Brownridge EA, Ivins BE.

Infect Immun. 1978 Mar;19(3):1061-7.

46.

A field survey of molluscicide-degrading microorganisms in the Caribbean area.

Etges FJ, Bell EJ, Ivins BE.

Am J Trop Med Hyg. 1969 May;18(3):472-6. No abstract available.

PMID:
4889831

Supplemental Content

Loading ...
Support Center